Literature DB >> 27181935

Protective effects of the exopolysaccharide Lasiodiplodan against DNA damage and inflammation induced by doxorubicin in rats: Cytogenetic and gene expression assays.

M B Mello1, C S Machado2, D L Ribeiro2, A F Aissa1, R V Burim1, M A Alves da Cunha3, G R M Barcelos4, L M G Antunes1, M L P Bianchi1.   

Abstract

The lasiodiplodan (LS) is a β-(1→6)-d-glucan produced by the fungus Lasiodiplodia theobromae and some of the biological activities of LS were reported as hypoglycemic, anticoagulant, anti-proliferative and anticancer action; however, its effects on DNA instability and modulation of gene expression are still unclear. Aims of study were investigate the genotoxic effects of lasiodiplodan, and its protective activity against DNA damage induced by doxorubicin (DXR) and its impact on the expression of genes associated with DNA damage and inflammatory response pathways. Therefore, Wistar rats were treated (15 days) orally with LS (5.0; 10 and 20mg/kg bw) alone and in combination with DXR (15mg/kg bw; administrated intraperitoneally on 14th day) as well as their respective controls: distilled water and DXR. Monitoring of DNA damage was assessed by comet and micronucleus (MN) assays and gene expression was evaluated by PCR-Arrays. Treatments with LS alone did not induce disturbances on DNA; when LS was given in combination with DXR, comet and MN formations were reduced to those found in the respective controls. Moreover, LS was able to reduce the disturbances on gene expressions induced by DXR treatment, since the animals that receive LS associated with DXR showed no alteration in the expression of genes related to DNA damage response. Also, DXR induced several up- and down-regulation of several genes associated to inflammatory process, while the animals that received LS+DXR had their gene expression patterns similar to those found in the control group. In conclusion, our results showed that LS did not induce disturbances on DNA stability and significantly reduce the DNA damage and inflammation caused by DXR exposure. In addition, we give further information concerning the molecular mechanisms associated to LS protective effects which seems to be a promising nutraceutical with chemopreventive potential.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antigenotoxic effects; DNA-damage; Gene expression; Inflammation; Lasiodiplodan; Nutraceuticals

Mesh:

Substances:

Year:  2016        PMID: 27181935     DOI: 10.1016/j.tox.2016.05.010

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  3 in total

1.  ELABELA and an ELABELA Fragment Protect against AKI.

Authors:  Hong Chen; Lin Wang; Wenjun Wang; Cheng Cheng; Yu Zhang; Yu Zhou; Congyi Wang; Xiaoping Miao; Jiao Wang; Chao Wang; Jianshuang Li; Ling Zheng; Kun Huang
Journal:  J Am Soc Nephrol       Date:  2017-06-05       Impact factor: 10.121

2.  The beneficial role of vitamin B12 in injury induced by ischemia/reperfusion: Beyond scavenging superoxide?

Authors:  Feng Li
Journal:  J Exp Nephrol       Date:  2021

3.  Antimicrobial and Histological Data Effect of Silybum marianum and Suaeda vermiculata Against Doxorubicin Induced Toxicity in Male Rats.

Authors:  Sarah Samir Othman; Safaa Mohamed Ali
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.